Compound class:
Synthetic organic
Comment: BCH070 is an antimalarial drug candidate, that with further optimization shows promise as a combination therapy with artemisinin to treat multidrug-resistant malaria [1].
|
|
References |
1. Clements RL, Streva V, Dumoulin P, Huang W, Owens E, Raj DK, Burleigh B, Llinás M, Winzeler EA, Zhang Q et al.. (2020)
A Novel Antiparasitic Compound Kills Ring-Stage Plasmodium falciparum and Retains Activity Against Artemisinin-Resistant Parasites. J Infect Dis, 221 (6): 956-962. [PMID:31616928] |